Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 291 | 555 | 165 | 332 | 202 |
| Cost of Goods | 117 | 300 | 102 | 230 | 67 |
| Gross Profit | 174 | 255 | 63 | 102 | 135 |
| Operating Expenses | 2,782 | 2,694 | 4,168 | 2,610 | 2,690 |
| Operating Income | -2,491 | -2,139 | -4,003 | -2,278 | -2,488 |
| Other Income | 40 | 64 | -27 | 29 | 46 |
| Pre-tax Income | -2,451 | -2,075 | -4,030 | -2,249 | -2,442 |
| Net Income Continuous | -2,451 | -2,075 | -4,030 | -2,249 | -2,442 |
| Net Income | $-2,451 | $-2,075 | $-4,030 | $-2,249 | $-2,442 |
| EPS Basic Total Ops | -0.05 | -0.04 | -0.08 | -0.04 | -0.05 |
| EPS Basic Continuous Ops | -0.05 | -0.04 | -0.08 | -0.04 | -0.05 |
| EPS Diluted Total Ops | -0.05 | -0.04 | -0.08 | -0.04 | -0.05 |
| EPS Diluted Continuous Ops | -0.05 | -0.04 | -0.08 | -0.04 | -0.05 |
| EBITDA(a) | $-2,333 | $-1,984 | $-3,850 | $-2,106 | $-2,318 |